These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 12062392)
1. Inhibition of human hepatitis B virus (HBV) by a novel non-nucleosidic compound in a transgenic mouse model. Weber O; Schlemmer KH; Hartmann E; Hagelschuer I; Paessens A; Graef E; Deres K; Goldmann S; Niewoehner U; Stoltefuss J; Haebich D; Ruebsamen-Waigmann H; Wohlfeil S Antiviral Res; 2002 May; 54(2):69-78. PubMed ID: 12062392 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of hepatitis B virus replication by Bay 41-4109 and its association with nucleocapsid disassembly. Wu GY; Zheng XJ; Yin CC; Jiang D; Zhu L; Liu Y; Wei L; Wang Y; Chen HS J Chemother; 2008 Aug; 20(4):458-67. PubMed ID: 18676226 [TBL] [Abstract][Full Text] [Related]
3. Antiviral activity of Bay 41-4109 on hepatitis B virus in humanized Alb-uPA/SCID mice. Brezillon N; Brunelle MN; Massinet H; Giang E; Lamant C; DaSilva L; Berissi S; Belghiti J; Hannoun L; Puerstinger G; Wimmer E; Neyts J; Hantz O; Soussan P; Morosan S; Kremsdorf D PLoS One; 2011; 6(12):e25096. PubMed ID: 22162746 [TBL] [Abstract][Full Text] [Related]
5. Anti-hepatitis B virus activity of wogonin in vitro and in vivo. Guo Q; Zhao L; You Q; Yang Y; Gu H; Song G; Lu N; Xin J Antiviral Res; 2007 Apr; 74(1):16-24. PubMed ID: 17280723 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of anti-hepatitis B virus (HBV) drugs using the HBV transgenic mouse: application of the semiquantitative polymerase chain reaction (PCR) for serum HBV DNA to monitor the drug efficacy. Kajino K; Kamiya N; Yuasa S; Takahara T; Sakurai J; Yamamura Ki; Hino O Biochem Biophys Res Commun; 1997 Dec; 241(1):43-8. PubMed ID: 9405231 [TBL] [Abstract][Full Text] [Related]
7. The Heteroaryldihydropyrimidine Bay 38-7690 Induces Hepatitis B Virus Core Protein Aggregates Associated with Promyelocytic Leukemia Nuclear Bodies in Infected Cells. Huber AD; Wolf JJ; Liu D; Gres AT; Tang J; Boschert KN; Puray-Chavez MN; Pineda DL; Laughlin TG; Coonrod EM; Yang Q; Ji J; Kirby KA; Wang Z; Sarafianos SG mSphere; 2018 Apr; 3(2):. PubMed ID: 29669885 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of hepatitis B virus by oxymatrine in vivo. Chen XS; Wang GJ; Cai X; Yu HY; Hu YP World J Gastroenterol; 2001 Feb; 7(1):49-52. PubMed ID: 11819732 [TBL] [Abstract][Full Text] [Related]
9. Characterization of antiviral activity of entecavir in transgenic mice expressing hepatitis B virus. Julander JG; Colonno RJ; Sidwell RW; Morrey JD Antiviral Res; 2003 Aug; 59(3):155-61. PubMed ID: 12927305 [TBL] [Abstract][Full Text] [Related]
10. Fusion protein of tapasin and hepatitis B core antigen 18‑27 enhances T helper cell type 1/2 cytokine ratio and antiviral immunity by inhibiting suppressors of cytokine signaling family members 1/3 in hepatitis B virus transgenic mice. Tang Y; Chen X; Zhang Y; Tang Z; Zhuo M; Li D; Wang P; Zang G; Yu Y Mol Med Rep; 2014 Apr; 9(4):1171-8. PubMed ID: 24535102 [TBL] [Abstract][Full Text] [Related]
11. High persistence rate of hepatitis B virus in a hydrodynamic injection-based transfection model in C3H/HeN mice. Peng XH; Ren XN; Chen LX; Shi BS; Xu CH; Fang Z; Liu X; Chen JL; Zhang XN; Hu YW; Zhou XH World J Gastroenterol; 2015 Mar; 21(12):3527-36. PubMed ID: 25834317 [TBL] [Abstract][Full Text] [Related]
12. Establishment and primary application of a mouse model with hepatitis B virus replication. Liu FJ; Liu L; He F; Wang S; Zhou TY; Liu C; Deng LY; Tang H World J Gastroenterol; 2007 Oct; 13(40):5324-30. PubMed ID: 17879401 [TBL] [Abstract][Full Text] [Related]
13. The hepatitis B virus-trimera mouse: a model for human HBV infection and evaluation of anti-HBV therapeutic agents. Ilan E; Burakova T; Dagan S; Nussbaum O; Lubin I; Eren R; Ben-Moshe O; Arazi J; Berr S; Neville L; Yuen L; Mansour TS; Gillard J; Eid A; Jurim O; Shouval D; Reisner Y; Galun E Hepatology; 1999 Feb; 29(2):553-62. PubMed ID: 9918935 [TBL] [Abstract][Full Text] [Related]
14. Efficacy of NVR 3-778, Alone and In Combination With Pegylated Interferon, vs Entecavir In uPA/SCID Mice With Humanized Livers and HBV Infection. Klumpp K; Shimada T; Allweiss L; Volz T; Lütgehetmann M; Hartman G; Flores OA; Lam AM; Dandri M Gastroenterology; 2018 Feb; 154(3):652-662.e8. PubMed ID: 29079518 [TBL] [Abstract][Full Text] [Related]
15. Viral Load Affects the Immune Response to HBV in Mice With Humanized Immune System and Liver. Dusséaux M; Masse-Ranson G; Darche S; Ahodantin J; Li Y; Fiquet O; Beaumont E; Moreau P; Rivière L; Neuveut C; Soussan P; Roingeard P; Kremsdorf D; Di Santo JP; Strick-Marchand H Gastroenterology; 2017 Dec; 153(6):1647-1661.e9. PubMed ID: 28851562 [TBL] [Abstract][Full Text] [Related]
16. Preclinical characterization of GLS4, an inhibitor of hepatitis B virus core particle assembly. Wu G; Liu B; Zhang Y; Li J; Arzumanyan A; Clayton MM; Schinazi RF; Wang Z; Goldmann S; Ren Q; Zhang F; Feitelson MA Antimicrob Agents Chemother; 2013 Nov; 57(11):5344-54. PubMed ID: 23959305 [TBL] [Abstract][Full Text] [Related]